News
Preferred shares offer lower risk and high yields; recent trades in DX-C and EFC-B have been profitable. Click here for more ...
Zacks Investment Research on MSN18h
Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results?GeneDx Holdings Corp. WGS is slated to report its first-quarter 2025 results on April 30, before the market opens. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback